Actual 10-year survival following hepatectomy for hepatocellular carcinoma

HPB

Volumn 16, Issue 9, 2014, Pages 830-835

  Franssen, Bernardo ^a   Jibara, Ghalib ^a   Tabrizian, Parissa ^a   Schwartz, Myron E ^a   Roayaie, Sasan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CANCER RECURRENCE; CANCER SURVIVAL; CANCER SURVIVOR; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER RESECTION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MICROVASCULATURE; OVERALL SURVIVAL; PORTAL HYPERTENSION; RETROSPECTIVE STUDY; TUMOR INVASION; ADVERSE EFFECTS; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; UNITED STATES;

AGED; BLOOD TRANSFUSION; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEW YORK CITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84905816570     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12206     Document Type: Article

References (24)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Llovet JM, Bru C, Bruix J,. (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19: 329-338.
3. Bruix J, Sherman M,. (2011) American Association for the Study of Liver Disease. Management of hepatocellular carcinoma: an update. Hepatology 53: 1020-1022.
4. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, etal. (2000) Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg 191: 381-388.
5. Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, etal. (2007) Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery 141: 330-339. (Pubitemid 46371307)
6. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, etal. (2000) Results of surgical and non-surgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 32: 1224-1229.
7. Grazi GL, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, Cavallari A, etal. (2001) Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 234: 71-78. (Pubitemid 32619337)
8. Gluer AM, Cocco N, Laurence JM, Johnston ES, Hollands MJ, Pleass HC, etal. (2012) Systematic review of actual 10-year survival following resection for hepatocellular carcinoma. HPB 14: 285-290.
9. Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, etal. (2006) Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 202: 275-283. (Pubitemid 43112487)
10. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J,. (2000) Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89: 500-507. (Pubitemid 30640096)
11. Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T, etal. (1996) Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg 224: 591-595. (Pubitemid 26384881)
12. Forner A, Reig ME, de Lope CR, Bruix J,. (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30: 61-74.
13. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, etal. (2005) Tumour size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11: 1086-1092. (Pubitemid 41341758)
14. Fong Y, Sun RL, Jarnagin W, Blumgart LH,. (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western centre. Ann Surg 229: 790-799; discussion 799-800.
15. Roayaie S, Blume IN, Thung SN, Guido M, Fiel MI, Hiotis S, etal. (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137: 850-855.
16. Katz SC, Shia J, Liau KH, Gonen M, Ruo L, Jarnagin WR, etal. (2009) Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 249: 617-623.
17. Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J,. (2012) Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 55: 132-140.
18. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, etal. (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicentre study. Surgery 137: 403-410. (Pubitemid 40432037)
19. Pawlik TM, Poon RT, Abdalla EK, Sarmiento JM, Ikai I, Curley SA, etal. (2004) Hepatitis serology predicts tumour and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. J Gastrointest Surg 8: 794-804.
20. Roayaie S, Haim MB, Emre S, Fishbein TM, Sheiner PA, Miller CM, etal. (2000) Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Western experience. Ann Surg Oncol 7: 764-770.
21. Yamanaka N, Tanaka T, Tanaka W, Yamanaka J, Yasui C, Kuroda N, etal. (1997) Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 79: 1509-1515. (Pubitemid 27154780)
22. Fukuda S, Itamoto T, Amano H, Kohashi T, Ohdan H, Tashiro H, etal. (2007) Clinicopathologic features of hepatocellular carcinoma patients with compensated cirrhosis surviving more than 10 years after curative hepatectomy. World J Surg 31: 345-352. (Pubitemid 46183522)
23. Forner A, Llovet JM, Bruix J,. (2012) Hepatocellular carcinoma. Lancet 379: 1245-1255.
24. Kaibori M, Kubo S, Nagano H, Hayashi M, Haji S, Nakai T, etal. (2013) Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma. World J Surg 37: 820-828.